Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas

NCT00165139 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2009-11-02

No results posted yet for this study

Summary

The main purpose of this study is to determine the short and long term side effects of a very intensive treatment, which includes combinations of chemotherapy drugs followed by radiation therapy and two transplants supported by peripheral blood progenitor cells (stem cells), for children with advanced stage neuroblastoma and sarcomas.

Conditions

  • Neuroblastoma
  • Ewings Sarcoma
  • Non-rhabdomyosarcoma Soft Tissue Sarcoma

Interventions

DRUG

Vincristine

Described under detailed description

DRUG

Cyclophosphamide

Described under detailed description

DRUG

Adriamycin

Described under detailed description

DRUG

Etoposide (VP-16)

Described under detailed description

DRUG

Cisplatin

Described under detailed description

DRUG

Carboplatin

Described under detailed description

DRUG

Melphalan

Described under detailed description

DRUG

Ifosfamide

Described under detailed description

DRUG

G-CSF (granulocyte-colony stimulating factor)

Described under detailed description

DRUG

Mesna

Described under detailed description

Sponsors & Collaborators

Principal Investigators

  • Lisa Diller, MD · Dana-Farber Cancer Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-01-31
Primary Completion
2000-11-30
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00165139 on ClinicalTrials.gov